XML 24 R16.htm IDEA: XBRL DOCUMENT v3.20.1
Note 11 - Stockholders' Equity
 3 Months Ended
Mar. 31, 2020
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
NOTE
11.
STOCKHOLDERS’ EQUITY
 
On
October 5, 2017,
we effected a 
one
-for-
ten
reverse stock split of our common stock. Our condensed consolidated financial statements and disclosures reflect these changes in capital structure for all periods presented.
 
On
June 12, 2015
and
June 13, 2016,
our shareholders approved
100,000,000
increases in our authorized common stock to
300,000,000
and
400,000,000,
respectively. On
October 2, 2017,
our shareholders approved a
300,000,000
decrease in our authorized common stock to
100,000,000.
 
The following table represents the change in our stockholders' equity for the
three
months ended
March 31, 2020 
and
2019:
 
 
 
 
Three Months Ended March 31, 2019
 
Common Stock
  
Paid in
  
Stock
  
Comprehensive
  
Non-controlling
  
Accumulated
  
Equity (Deficiency)
 
Shares
  
Amount
  
Capital
  
Subscription
  
Income
  
interest
  
Deficit
  
in Equity
   Balance December 31, 2018
3,863,019
  
$ 386.30
  
$183,246,232
  
$ -
  
$ (2,232,163)
  
$ (125,737)
  
$(172,292,252)
  
$ 8,596,466
Share based compensation
2,448
  
0.24
  
15,006
  
-
  
-
  
-
  
-
  
15,006
Net loss
-
  
-
  
-
  
-
  
-
  
(13,966)
  
(1,120,847)
  
(1,134,813)
Comprehensive loss - foreign currency translation
-
  
-
  
-
  
-
  
(14,561)
  
-
  
-
  
(14,561)
   Balance March 31, 2019
3,865,467
  
$ 386.55
  
$183,261,238
  
$ -
  
$ (2,246,724)
  
$ (139,703)
  
$(173,413,099)
  
$ 7,462,098
 
 
   
Three Months Ended March 31, 2020
  
   
Common Stock
    
Paid in
    
Stock
    
Comprehensive
    
Non-controlling
    
Accumulated
    
Equity (Deficiency)
  
   
Shares
    
Amount
    
Capital
    
Subscription
    
Income
    
interest
    
Deficit
    
in Equity
  
Balance December 31, 2019
    
4,111,082
     $
410.66
     $
185,297,069
     $
-
     $
(2,274,187
 )   $
(231,999
 )   $
(178,750,634
 )   $
4,040,660
  
Share based compensation
    
14,672
      
1.47
      
45,896
      
-
      
-
      
-
      
-
      
45,897
  
Expenses paid in connection with ESOUSA transaction
    
-
      
-
      
(5,000
 )    
-
      
-
      
-
      
-
      
(5,000
 )
Net loss
    
-
      
-
      
-
      
-
      
-
      
(11,228
 )    
(1,366,216
 )    
(1,377,444
 )
Comprehensive loss - foreign currency translation
    
-
      
-
      
-
      
-
      
130,813
      
-
      
-
      
130,813
  
Balance March 31, 2020
    
4,125,754
     $
412.13
     $
185,337,965
     $
-
     $
(2,143,374
 )   $
(243,227
 )   $
(180,116,849
 )   $
2,834,927
  
 
Equity Incentive Plan Activity
 
On
December 5, 2013,
our shareholders approved the Net Element International, Inc.
2013
Equity Incentive Plan (as amended to date, the
“2013
Plan”). Awards under the
2013
Plan
may
be granted in any
one
or all of the following forms: (i) incentive stock options meeting the requirements of Section
422
of the Internal Revenue Code of
1986,
as amended; (ii) non-qualified stock options (unless otherwise indicated, references to “Options” include both Incentive Stock Options and Non-Qualified Stock Options); (iii) stock appreciation rights, which
may
be awarded either in tandem with Options or on a stand-alone basis; (iv) shares of common stock that are restricted; (v) units representing shares of common stock; (vi) units that do
not
represent shares of common stock but which
may
be paid in the form of common stock; and (vii) shares of common stock that are
not
subject to any conditions to vesting.
 
On
November 27, 2018,
our shareholders approved an amendment to the
2013
Plan to increase the number of shares of the Company’s common stock available for issuance by
178,900
shares resulting in the aggregate of
773,000
shares authorized for issuance under the
2013
Plan.
 
On
October 23, 2019,
our shareholders approved an amendment to the
2013
Plan to increase the number of shares of the Company’s common stock available for issuance by
177,000
shares resulting in the aggregate of
950,000
shares authorized for issuance under the
2013
Plan.
 
The maximum aggregate number of shares of common stock available for award under the
2013
Plan at
March 31, 2020 
and
December 31, 2019 
was
237,764
and
252,436,
respectively. The
2013
Plan is administered by the compensation committee.
 
2013
Equity Incentive Plan - Unrestricted Shares and Stock Options
 
During the
three
months ended
March 31, 2020 
and
2019,
we issued common stock pursuant to the
2013
Plan to the members of our Board of Directors and recorded a compensation charge of
$7,500
 and
$15,006,
respectively.
 
At
March 31, 2020 
and
December 31, 2019,
we had
154,005
 incentive stock options outstanding with a weighted average exercise price of
$10.73
 
and a weighted average remaining contract term of
7.83
years
 
at
March 31, 2020
 
and
8.08
years at
December 31, 2019,
respectively. All of the stock options were anti-dilutive at
March 31, 2020 
and
December 31, 2019.